bmiMD Review 2026: Is the $99/mo Compounded GLP-1 Plan Actually Worth It?

Reviewed by RC Nelson, Health & Wellness Writer. Last updated May 2026.

Key Takeaways

• $99/mo on the 12-month plan for compounded semaglutide, scaling up to $129/mo month-to-month
• Same price at every dose (no surcharge as your prescription strength climbs)
• Same-day telehealth consult with a board-certified provider
• 100% money-back guarantee if you are not approved for treatment
• HSA/FSA eligible, buy-now-pay-later available
• USP 797 / USP 85 tested compounding from licensed US pharmacies
• Available in all 50 states
• Only compounded options (no brand-name Wegovy, Ozempic, or Zepbound)

What Is bmiMD?

bmiMD is a telehealth platform that prescribes compounded semaglutide and tirzepatide for weight loss. The pitch is straightforward: pick how long you want to commit, pay upfront, and the longer your commitment the cheaper your monthly cost gets. That structure is uncommon in the GLP-1 space, where most platforms either charge a flat monthly rate or hide the savings behind a first-month promo.

What makes bmiMD worth a serious look is the math on the longer plans. $99/mo for compounded semaglutide is at the floor of what is realistic in this market. The catch is that you are paying $1,188 upfront to get there.

Pricing Breakdown

Here is the full plan ladder for compounded semaglutide:

A 10% subscribe-and-save discount applies on top at checkout, which pushes the 12-month plan effective rate even lower.

For context against other compounded GLP-1 platforms:

The two real competitors at the $99 floor are bmiMD and GobyMeds. GobyMeds wins on flexibility (no 12-month prepay). bmiMD wins on the same-price-at-every-dose guarantee, since GobyMeds pricing can shift with your dose ladder.

How It Works

1. Pick a plan. Decide whether you want the 12-month, 6-month, 3-month, or month-to-month tier. Pay upfront for whichever plan length you choose.
2. Complete the medical questionnaire. Standard intake covering your BMI, medical history, current medications, and weight-loss goals.
3. Same-day telehealth consult. A board-certified provider reviews your information and meets with you to evaluate eligibility. This is usually same-day after you complete intake.
4. Prescription fills at a licensed pharmacy. If approved, your script is sent to an independent compounding pharmacy and shipped to your door. Shipping is free on subscription orders.
5. Ongoing support. Unlimited messaging with your provider for dosage and side-effect questions, plus 24/7 clinician access.

Medications

The two main weight-loss options are:

Compounded Semaglutide. Same active ingredient as Ozempic and Wegovy, prepared by a US-licensed compounding pharmacy. Injectable. This is what the $99-$129/mo pricing applies to.

Compounded Tirzepatide. Same active ingredient as Mounjaro and Zepbound. Dual-action (GLP-1 plus GIP), generally produces faster and larger weight loss in clinical evidence than semaglutide alone. Priced higher than the semaglutide tiers.

bmiMD also offers microdose versions of both, which are typically used for patients sensitive to side effects or those titrating up slowly.

What bmiMD does not offer: brand-name FDA-approved GLP-1s. If you need actual Wegovy or Zepbound (for example because your insurance covers branded but not compounded), look at Eden, Ro, or Hims instead.

Compounding and Safety

This is the part most $99/mo platforms gloss over, and bmiMD actually puts the details on the page. Their compounding pharmacies are:

• State-licensed sterile compounding facilities
• FDA-registered (different from FDA-approved, which compounded medications are not)
• Potency tested every 3-6 months to stay within plus or minus 10% of target strength
• Sterility tested to USP 797 standards
• Endotoxicity tested to USP 85 limits
• pH balanced for injection comfort

That is a more transparent disclosure than most compounded GLP-1 platforms publish. The hard rule remains: compounded medications are not FDA-approved, and you are trusting the pharmacy's testing protocols rather than the FDA's. That trade-off comes with every compounded GLP-1 program, not just bmiMD.

Pros

The 12-month price is real. $99/mo for compounded semaglutide with provider access included is genuinely at the cheap end of this market. Most platforms quoting that number bury fees somewhere else.

Same price at every dose. Some compounded GLP-1 programs raise your monthly cost as your prescription strength climbs from 0.25mg to 2.4mg. bmiMD does not. The plan price you start with is the plan price you keep.

Same-day telehealth consult. Most async-only competitors make you wait 24-48 hours for a chart review. bmiMD's same-day video consult means you can typically be approved and shipped within the first week.

Money-back guarantee. 100% refund if you are not approved is a fair backstop on the upfront commitment.

Transparent compounding disclosure. Listing the actual USP standards and testing cadence is a trust signal most $99 platforms skip.

Cons

The 12-month plan locks you in. Paying $1,188 upfront to get the headline price is a real commitment. If GLP-1 treatment does not agree with you or your insurance starts covering Wegovy, you are out the prepaid balance (minus whatever bmiMD's refund policy returns for unused doses).

$129/mo month-to-month is mid-pack. If you are not willing to prepay, bmiMD's monthly rate is competitive but not actually cheap. At that price you can also get Eden or comparable platforms with different feature sets.

Compounded only. No FDA-approved Wegovy, Ozempic, or Zepbound. For patients who specifically want branded medication, this rules bmiMD out.

Does not bill insurance. Cash-pay only. HSA/FSA helps but does not change the underlying out-of-pocket math.

bmiMD vs. the Competition

Who Is bmiMD Best For?

Three types of patients should look at bmiMD:

1. Long-term planners who want the cheapest compounded GLP-1. If you have already decided GLP-1 treatment is part of your year-long plan and you have the cash for upfront prepay, $99/mo locked in for 12 months is one of the best rates in the market.

2. Patients who hate dose-tiered pricing. If you have been burned by a program that started at $179/mo and climbed to $299/mo as your dose went up, bmiMD's flat-rate-at-every-dose structure removes that variable.

3. People who want a same-day approval. Most $99-tier compounded GLP-1 platforms run async. bmiMD's same-day telehealth consult is faster than the typical 24-48 hour chart review.

It is not the right fit if you want the flexibility to cancel any month, want a brand-name FDA-approved option, or have insurance that covers Wegovy or Zepbound.

The Bottom Line

bmiMD's strength is exactly what they advertise: the cheapest compounded semaglutide tier in the market with a same-price-at-every-dose guarantee and an actual money-back backstop if you are not approved. The 12-month plan at $99/mo is a real number, not a teaser.

The cost of that pricing is the prepayment. You have to be reasonably confident GLP-1 treatment is going to work for you before you write a $1,188 check, because cash-out flexibility is the explicit trade-off.

For patients who already know they want long-term compounded semaglutide and want to lock in the lowest sustainable price, bmiMD is one of the best options on the market in May 2026. For everyone else, the month-to-month tier at $129/mo is fine but not differentiating.

Ready to get started? Visit bmiMD to see if you qualify and to lock in the 12-month plan rate.

---

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Compounded medications are not FDA-approved. Individual results vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you are experiencing a medical emergency, call 911.